This HTML5 document contains 129 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n12http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42965343
rdf:type
wikibase:Item
schema:description
2010 nî lūn-bûn 2010年论文 vetenskaplig artikel artigo científico naučni članak мақолаи илмӣ article científic научна статия article scientific scientific article published on 19 July 2010 2010年论文 2010年論文 ১৯ জুলাই ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artikulong pang-agham scienca artikolo videnskabelig artikel bilimsel makale научни чланак articolo scientifico vědecký článek 2010年论文 scientific article published on 19 July 2010 2010年の論文 vitenskapelig artikkel 2010年论文 teaduslik artikkel επιστημονικό άρθρο 2010年論文 wissenschaftlicher Artikel artículo científico publicado en 2010 مقالة علمية نشرت في 19 يوليو 2010 научная статья სამეცნიერო სტატია 2010年论文 2010年論文 מאמר מדעי vitskapeleg artikkel artigo científico 2010年論文 bài báo khoa học наукова стаття, опублікована в липні 2010 artikel ilmiah научни чланак article scientifique บทความทางวิทยาศาสตร์ 2010년 논문 scientific article published on 19 July 2010 artigo científico 2010年論文 artykuł naukowy wetenschappelijk artikel articol științific artikull shkencor artículu científicu espublizáu en 2010 tieteellinen artikkeli tudományos cikk vedecký článok 2010年论文
p:P577
wds:Q42965343-8B2AF50E-8136-40A8-9D92-2B1763ED353D
wdt:P577
2010-07-19T00:00:00Z
p:P407
wds:Q42965343-457C7E50-B23E-4E54-9A53-4717085B5F40
wdt:P407
wd:Q1860
p:P2093
wds:Q42965343-D9DF2BBD-BCE1-4EE9-A10E-6E8A308AE043 wds:Q42965343-A293CADA-F00B-4386-B203-9ACF50F26943 wds:Q42965343-4BA1BE03-51BE-4AA5-8A38-2BE78FB6D9D6 wds:Q42965343-1EB33D7D-EB4A-482C-BA8D-A6AD94543734 wds:Q42965343-0161EAA6-2E4A-4E5F-A9CB-7DD124494371
wdt:P2093
Xavier Leleu Denis Caillot Catherine Guerin-Charbonnel Brigitte Kolb Cyrille Hulin
rdfs:label
Bortezomib plus dexamethasone induction improves outcome of patients with t Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).
skos:prefLabel
Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p). Bortezomib plus dexamethasone induction improves outcome of patients with t
schema:name
Bortezomib plus dexamethasone induction improves outcome of patients with t Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p).
p:P50
wds:Q42965343-435AC91C-41F6-44AE-8000-954665755977 wds:Q42965343-1769B048-AA13-4EC4-AC5C-1B395FC40527 wds:Q42965343-7B9B0A40-E6FE-4EC8-B60C-4691FF7E28DB wds:Q42965343-842A4D8E-3C02-4E1F-990A-275FEC77BFA3 wds:Q42965343-594028C5-CAFA-44FA-A1AB-84AABFC2247C wds:Q42965343-BE3B5768-C9A2-41E5-9353-63A388C5DF89 wds:Q42965343-977D12DE-438D-477C-9EC6-FC0933EFC651 wds:Q42965343-9F893F19-F638-491A-A34E-C66835550AE6 wds:Q42965343-E3ED5AAF-DEDF-49CB-9794-93019432A645 wds:Q42965343-E4F96226-2DC3-481D-8A67-AC00FAB87E4A wds:Q42965343-F72CD228-5149-43C2-B292-1CADB3A55C18 wds:Q42965343-C6F76902-8D6F-49F1-917B-50C717D71D7D wds:Q42965343-C92FA822-6C72-4458-889E-6F926F046D26 wds:Q42965343-CC23FB02-3300-4DB5-B3A6-A5DCB977C572 wds:Q42965343-F8C78AAF-75B9-44F8-BF16-5694700ED2F5
wdt:P50
wd:Q117252283 wd:Q3167165 wd:Q89459600 wd:Q99254932 wd:Q117224781 wd:Q87734443 wd:Q42165930 wd:Q61112732 wd:Q114340071 wd:Q114340067 wd:Q57306384 wd:Q114340053 wd:Q85789960 wd:Q56380622 wd:Q91591759
p:P1476
wds:Q42965343-E74DD82D-C3C5-4992-92EC-F35E325BD804
wdt:P1476
Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p)
p:P304
wds:Q42965343-6F48A0BA-8DE2-4FE6-86BF-D7A09C042E0A
wdt:P304
4630-4634
p:P31
wds:Q42965343-A2997EFE-D9D2-4EBF-A948-BB0E895A86A3
wdt:P31
wd:Q13442814
p:P921
wds:Q42965343-91793B29-E96E-439F-819D-D0757720969F
wdt:P921
wd:Q422252
p:P698
wds:Q42965343-76CB26B8-139E-4ABA-966F-35BC01C8D08D
wdtn:P698
n9:20644101
wdt:P698
20644101
p:P1433
wds:Q42965343-B52E297A-ECEA-4FDC-BD67-985FEBF54F4B
wdt:P1433
wd:Q400292
p:P433
wds:Q42965343-8A3E5DCB-CA0D-4E47-BE29-731A0AA504A1
p:P478
wds:Q42965343-99DA0C35-C3D6-414A-BCB6-9393B8AABAF5
wdt:P433
30
wdt:P478
28
p:P356
wds:Q42965343-5DAFCF3D-F7A0-47A7-A0A1-143DDB96F194
wdtn:P356
n12:JCO.2010.28.3945
wdt:P356
10.1200/JCO.2010.28.3945